MEI PHARMA INC's ticker is MEIP and the CUSIP is 55279B202. A total of 52 filers reported holding MEI PHARMA INC in Q4 2022. The put-call ratio across all filers is 0.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $480,690 | +67.2% | 2,100,000 | +78.0% | 0.04% | +104.5% |
Q4 2022 | $287,448 | -35.4% | 1,180,000 | +2.6% | 0.02% | -35.3% |
Q3 2022 | $445,000 | -33.2% | 1,150,000 | +4.5% | 0.03% | -26.1% |
Q2 2022 | $666,000 | +112.8% | 1,100,000 | +111.5% | 0.05% | +119.0% |
Q1 2022 | $313,000 | -38.3% | 520,000 | +173.7% | 0.02% | -27.6% |
Q4 2021 | $507,000 | – | 190,000 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TLS Advisors LLC | 2,010,285 | $490 | 2.42% |
Anson Funds Management LP | 10,617,959 | $2,586,535 | 0.43% |
NEA Management Company, LLC | 8,533,072 | $2,078,656 | 0.12% |
Boxer Capital, LLC | 2,913,091 | $709,629 | 0.04% |
Investmark Advisory Group LLC | 136,000 | $33,130 | 0.02% |
CARLSON CAPITAL L P | 1,180,000 | $287,448 | 0.02% |
Mesirow Financial Investment Management, Inc. | 20,486 | $4,990 | 0.02% |
Artal Group S.A. | 1,000,000 | $244 | 0.01% |
Annandale Capital, LLC | 100,000 | $24 | 0.01% |
ACADIAN ASSET MANAGEMENT LLC | 4,758,364 | $1,158 | 0.01% |